Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'24
Mar'18
Sep'17
Mar'17
Sep'16
Mar'16
Quarterly Analysis Highlights - YoY
Analysis not available as Data has been published for only 1 period
Compare Quarterly Results Of Ganga Pharma. With
Figures in Cr
Standalone Quarterly Results
Change(INR)
Change(%)
Net Sales
1.31
0.04
1.27
3,175.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1.31
0.04
1.27
3,175.00%
Raw Material Cost
0.70
0.00
0.70
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-0.08
0.00
-0.08
Employee Cost
0.29
0.01
0.28
2,800.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.52
0.01
0.51
5,100.00%
Total Expenditure (Excl Depreciation)
1.43
0.02
1.41
7,050.00%
Operating Profit (PBDIT) excl Other Income
-0.12
0.02
-0.14
-700.00%
Other Income
0.29
0.00
0.29
Operating Profit (PBDIT)
0.17
0.02
0.15
750.00%
Interest
0.09
0.00
0.09
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
0.08
0.02
0.06
300.00%
Depreciation
0.02
0.00
0.02
Profit Before Tax
0.07
0.01
0.06
600.00%
Tax
0.04
0.00
0.04
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
0.02
0.01
0.01
100.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
0.02
0.01
0.01
100.00%
Equity Capital
0.05
0.31
-0.26
-83.87%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.00
0.32
3.68
1,150.00%
Diluted Earnings per share
0.05
0.05
0.00
Operating Profit Margin (Excl OI)
-9.16%
50.00%
0.00
-59.16%
Gross Profit Margin
6.11%
50.00%
0.00
-43.89%
PAT Margin
1.53%
25.00%
0.00
-23.47%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1.31 Cr
in Sep 2024Figures in Cr
Quarterly - Standalone Net Profit
Standalone Net Profit 0.02 Cr
in Sep 2024Figures in Cr
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.12 Cr
in Sep 2024Figures in Cr
Quarterly - Interest
Interest 0.09 Cr
in Sep 2024Figures in Cr
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -9.16%
in Sep 2024Figures in %






